Boğaziçi University Center for Targeted Therapy Technologies - CT³

Boğaziçi CT³ has a clear national mandate of hosting research/researchers focusing on "targeted treatment technologies (T³ )" and to thrive to become a worldwide pioneer of novel technologies in this field. It was spun out from Boğaziçi University Life Sciences and Technologies Application and Research Center (Boğaziçi LifeSci) within the last months of 2024, and has begun to receive a special financial support as a thematic Center of Excellence (Law #6550 of Turkey) . All groundbreaking T³ research/technological advancements, such as in vivo "smart" devices, targeted nanomedicine and special cellular treatments, will be boosted to be translated into clinical use and economic value!